Release Date: 19/02/15 11:45 Summary: 1300SMILES prospers in the new era Price Sensitive: No Download Document 403.88KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%